Centrexion stock hits 52-week low at $0.79 amid market challenges
In a turbulent market environment, Centrexion Therapeutics Corp (CNTX) stock has touched a new 52-week low, with shares falling to $0.79. According to InvestingPro data, this represents a stark ...
Cadrenal Therapeutics Announces New Chief Medical Officer in Recent SEC Filing
Cadrenal Therapeutics, a biopharmaceutical company listed on the Nasdaq under the ticker symbol CVKD, made a public announcement of leadership changes through an 8-K SEC filing on February 4, 2025.
Gilead Sciences (GILD) Q4 Earnings: What To Expect
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be announcing earnings results tomorrow afternoon. Here’s what to expect. Gilead Sciences beat analysts’ revenue expectations by 7.4% last ...
BioAsia 2025 conclave to propel healthcare innovation in Hyderabad
Hyderabad: BioAsia 2025, the 22nd edition of what is touted as one of the largest gatherings of experts and global honchos ...
Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief ...
Amgen Skids On A Surprise Setback For One Of Its Obesity Drugs
Amgen stock skidded late Tuesday after the biotech behemoth said the FDA placed one of its obesity treatments on clinical ...